NO974143D0 - Farmakologisk anvendelse av visse cystinderivater - Google Patents

Farmakologisk anvendelse av visse cystinderivater

Info

Publication number
NO974143D0
NO974143D0 NO974143A NO974143A NO974143D0 NO 974143 D0 NO974143 D0 NO 974143D0 NO 974143 A NO974143 A NO 974143A NO 974143 A NO974143 A NO 974143A NO 974143 D0 NO974143 D0 NO 974143D0
Authority
NO
Norway
Prior art keywords
cysteine derivatives
pharmacological use
certain cysteine
certain
pharmacological
Prior art date
Application number
NO974143A
Other languages
English (en)
Other versions
NO974143L (no
Inventor
Haakan Bergstrand
Knut Pettersson
Christer Westerlund
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO974143L publication Critical patent/NO974143L/no
Publication of NO974143D0 publication Critical patent/NO974143D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225Polycarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
NO974143A 1995-03-14 1997-09-09 Farmakologisk anvendelse av visse cystinderivater NO974143D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9500897A SE9500897D0 (sv) 1995-03-14 1995-03-14 The pharmacological use of certain cystine derivatives
PCT/SE1996/000320 WO1996028149A1 (en) 1995-03-14 1996-03-12 The pharmacological use of certain cystine derivatives

Publications (2)

Publication Number Publication Date
NO974143L NO974143L (no) 1997-09-09
NO974143D0 true NO974143D0 (no) 1997-09-09

Family

ID=20397536

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974143A NO974143D0 (no) 1995-03-14 1997-09-09 Farmakologisk anvendelse av visse cystinderivater

Country Status (24)

Country Link
US (1) US5883126A (no)
EP (1) EP0814798A1 (no)
JP (1) JPH11501916A (no)
KR (1) KR19980703055A (no)
CN (1) CN1183718A (no)
AR (1) AR002716A1 (no)
AU (1) AU701287B2 (no)
BR (1) BR9607225A (no)
CA (1) CA2214831A1 (no)
CZ (1) CZ288219B6 (no)
EE (1) EE03382B1 (no)
HU (1) HUP9801985A3 (no)
IL (1) IL117465A (no)
IS (1) IS4554A (no)
NO (1) NO974143D0 (no)
NZ (1) NZ303781A (no)
PL (1) PL183234B1 (no)
SE (1) SE9500897D0 (no)
SK (1) SK282448B6 (no)
TR (1) TR199700945T1 (no)
TW (1) TW385249B (no)
UA (1) UA42830C2 (no)
WO (1) WO1996028149A1 (no)
ZA (1) ZA961749B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2235245A1 (en) * 1995-10-17 1997-04-24 Dovetail Technologies, Inc Low molecular weight cell, bone marrow and immune stimulants
DE19821625C1 (de) * 1998-05-15 2000-01-05 Merck Patent Gmbh Pharmazeutische Zubereitung
SE9900438D0 (sv) * 1999-02-10 1999-02-10 Astra Ab The pharmacological use of certian cystine derivatives

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR8205M (no) * 1968-12-20 1970-09-14
US3878305A (en) * 1972-05-25 1975-04-15 Procter & Gamble Fortification of foodstuffs with n-acyl derivatives of sulphur-containing l-amino acids
FR2289179A1 (fr) * 1974-10-28 1976-05-28 Morelle Jean Sels metalliques de lipoaminoacides
US3952115A (en) * 1975-04-02 1976-04-20 The Procter & Gamble Company Fortification of foodstuffs with N-acyl derivatives of sulfur-containing L-amino acid esters
FR2503151A1 (fr) * 1981-04-02 1982-10-08 Morelle Jean Butyryminoacides soufres. mode de preparation. emploi comme element keratogenique chez l'homme et l'animal et comme agent de fertilisation chez les vegetaux
GB2097256B (en) * 1981-04-02 1985-05-30 Morelle Jean V Compositions containing n-butyryl alphaaminoacids
US4708965A (en) * 1985-09-16 1987-11-24 Morgan Lee R Method of treating herpes virus infections with N,N'-diacetylcystine and derivatives
US4827016A (en) * 1985-09-16 1989-05-02 Morgan Lee R Method and compounds for reducing dermal inflammations
US4724239A (en) * 1985-09-16 1988-02-09 Morgan Lee R Method of treating chemical ulcers with N,N'-diacetylcystine, N-acetyl homocysteine and N-acetyl cysteine
JPS62195356A (ja) * 1986-02-20 1987-08-28 Seiwa Kasei:Kk シスチン誘導体及びその塩
IL98310A (en) * 1990-06-08 1996-08-04 Astra Ab Medicinal preparations containing a history of cystine
TW221376B (no) * 1990-06-28 1994-03-01 Astra Ab
IT1249650B (it) * 1991-05-29 1995-03-09 Poli Ind Chimica Spa N-(5-tioxo-l-prolil)-l-cisteina e suoi derivati, loro preparazione ed impiego terapeutico
SE9103572D0 (sv) * 1991-11-29 1991-11-29 Astra Ab Organic salts of n,n'-diacetyl cystine
CA2125888C (en) * 1992-01-06 2002-08-27 Harry B. Demopoulos Pharmaceutically active antioxidant containing composition and the method of its use to prevent and treat restenosis following angioplasty
DE4224670A1 (de) * 1992-07-25 1994-01-27 Boehringer Mannheim Gmbh Verwendung von â,w-Dicarbonsäuren als Fibrinogensenker

Also Published As

Publication number Publication date
NO974143L (no) 1997-09-09
TR199700945T1 (xx) 1998-02-21
CZ288219B6 (en) 2001-05-16
TW385249B (en) 2000-03-21
AU701287B2 (en) 1999-01-21
CZ280497A3 (cs) 1998-01-14
UA42830C2 (uk) 2001-11-15
MX9706825A (es) 1997-11-29
IS4554A (is) 1997-08-27
IL117465A (en) 2000-07-26
KR19980703055A (ko) 1998-09-05
HUP9801985A2 (hu) 1998-12-28
PL322328A1 (en) 1998-01-19
IL117465A0 (en) 1996-07-23
EP0814798A1 (en) 1998-01-07
SE9500897D0 (sv) 1995-03-14
BR9607225A (pt) 1998-07-07
EE9700229A (et) 1998-04-15
CA2214831A1 (en) 1996-09-19
PL183234B1 (pl) 2002-06-28
SK282448B6 (sk) 2002-02-05
EE03382B1 (et) 2001-04-16
US5883126A (en) 1999-03-16
HUP9801985A3 (en) 2000-07-28
ZA961749B (en) 1996-09-16
AR002716A1 (es) 1998-04-29
NZ303781A (en) 2001-03-30
JPH11501916A (ja) 1999-02-16
WO1996028149A1 (en) 1996-09-19
AU5018596A (en) 1996-10-02
SK120797A3 (en) 1998-02-04
CN1183718A (zh) 1998-06-03

Similar Documents

Publication Publication Date Title
BR9507179A (pt) Derivados de 3-aril-4-hidróxi-delta3-dihidrotiofena
IS2268B (is) Gúanín afleiður
NO953244L (no) Derivater av cyklodepeptid PF 1022
DE69610698D1 (de) Chinazolin-derivate
EE9800227A (et) 17ß-karboksü-, karbotio- ja amiidandrostaanide laktoonderivaadid
ITMI951020A0 (it) Derivati di diarildiammine
NO20005187D0 (no) n-sats syntese av 2-oksazolidinonderivater
KR970000222A (ko) 팩리택셀 유도체의 전구약물
DE69601527T2 (de) Pyrrolylbenzimidazol-Derivate
ATA100695A (de) Prothrombin-derivate
NO973455D0 (no) Dermatologisk anvendelse av Vitamin-D-derivater
FI944016A (fi) Makrolidien fluorisokerijohdannaiset
NO944906L (no) Ny anvendelse av benzo[gÅkinolinderivater
BR9607046A (pt) Derivados de 3-pirrolidiliden-2-ona-cefalosporinas
NO974143D0 (no) Farmakologisk anvendelse av visse cystinderivater
NO940190D0 (no) Anvendelse av x-ketoglutarat
ATE202093T1 (de) 4-amino-benzoylguanidin-derivate
BR9609723A (pt) Derivados da tricetona
FI942576A0 (fi) Behandling av plasma
NO931399D0 (no) Anvendelse av naturstein
ATE202088T1 (de) 4-mercapto-benzoylguanidin-derivate
FI942238A (fi) Furoimidatsolijohdannaisten asymmetrinen hydraus
BR9704770A (pt) Derivados de 1-carba-(detia)-cefalosporina
NO974458D0 (no) Fremstilling av cis-4-O-beskyttede-2-cyklopentenolderivater
NO934692D0 (no) Asymmetrisk hydrogenering av dihydrofuro-imidasolderivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application